Depression and anxiety as risk factors for female sexual pain

Abstract

Background

Female sexual pain is a complex multifactorial condition. Most of researches have focused on underlying biomedical factors. Although psychological, psychiatric, and relational factors have been studied as possible correlates, limited research has been made in this area about the Egyptian population. The present study aimed to evaluate prevalence of female sexual pain among a sample of Egyptian females and detect its correlation with depression and anxiety. Female sexual function index (FSFI) was used to evaluate sexual pain in 450 women calculating their pain domain scores. Their scores were correlated to demographic data, genital health complaints, depression, and anxiety symptoms.

Results

The prevalence of marked severe sexual pain was 31.6% and that of trivial pain was 68.4% in the studied group. In the study group, 75 (16.7%) females had depressive symptoms, and 40 (8.9%) females had anxiety symptoms. Patients with severe depression had significantly marked severe pain than patients with minimal depression (p < 0.001 respectively). Patients with severe anxiety had significantly lower pain score than patients without (p < 0.001). Pain score had significant negative correlation with each of the depression score (r − 0.524, p < 0.001) and the anxiety score (r − 0.305, p < 0.001). Patients with gynecological causes especially fungal infection had significantly severe marked pain than patients without any other physical causes (< 0.001).

Conclusions

Anxiety, depression, and the presence of gynecological causes especially fungal infection were significantly independent risk factors for more sexual pain.

Background

Pain can be a defining characteristic of sexual disorders. Dyspareunia, or pain during intercourse, affects between 12 and 44% of women [1,2,3].

Female sexual pain is a complex multi-factorial condition. Most of researches have focused on underlying biomedical factors. Although psychological, psychiatric, and relational factors have been studied as possible correlates, data are still controversial [4, 5].

Elevated rates of sexual problems have been reported in women diagnosed with panic disorder, anxiety disorders, and depression that have been associated with decreased lubrication, decreased sexual satisfaction, increased pain during intercourse or sexual activity, and more orgasmic problems [6].

Some of female sexual pain etiologies are vulvovaginal candidiasis, pelvic inflammatory diseases, chronic pelvic pain, and painful outcomes of delivery [7].

The aim of this study is to evaluate prevalence of female sexual pain among a sample of Egyptian females and to estimate the association between female sexual pain and both of anxiety and depression in Fayoum governorate, Egypt.

Methods

This is a cross-sectional study which included 450 married sexually active females evaluating their sexual pain. Four hundred and fifty females aged 18–66 years old were selected from three districts of Fayoum governorate (Fayoum district, Sennores, and Itsa). They were selected randomly (simple random method) from primary health care centers, dermatology and family planning clinics of Fayoum University, and general hospitals of the governorate. Subjects who had no sexual activity within the past month, unmarried, divorced, or widow were excluded from the study.

This study was approved by the Ethical committee of Faculty of Medicine, Fayoum University, and was done in accordance to the Declaration of Helsinki. Before obtaining informed consent from the participants, full explanation was given about the nature and aim of the study. They volunteered to participate and had the right to end their participation at any stage of the interview. All participants’ information was kept confidential and was used only for research purposes.

Subjects were assessed for the following:

• 1. Demographic characteristics including age, educational level, age of marriage, occupation, etc.

• 2. Assessment of gynecological and past medical history to search for risk factors including chronic disease (e.g., hypertension, cardiovascular disease, neurological disease, or diabetes), previous pelvic surgery (gynecologic, urologic, or colorectal surgeries), menstrual cycle regularities, contraception methods, and genital causes of pain as skin rash, ulcers, inflammation, and others.

• 3. Sexual functions using a self-administered detailed 19-item questionnaire (female sexual function index (FSFI)) [8] which assess the sexual functioning during the past 4 weeks. The Arabic validated version of FSFI [9] was used to assess the sexual function of the subjects.

According to the FSFI, sexual function domains included sexual desire, arousal, lubrication, orgasm, satisfaction, and pain during sexual intercourse. Here, we calculated domain score for pain only as it was our concern in this study.

Pain was assessed as frequency during vaginal penetration, frequency following vaginal penetration, and level during or following vaginal penetration with 3 questions 17, 18, and 19 respectively (score range 0–5 for each question). Pain score was obtained by adding the pain domain score and was calculated by multiplying the sum by the pain domain factor (0.4).

Pain score was analyzed as zero for no pain (no sexual activity) and from 1–6 for pain. According to FSFI, one is minimum score (maximum degree of pain) while 6 is maximum score (very low or no pain).

The pain score was categorized into marked and trivial pain based on a cutoff ≤ 3.6 for marked pain and > 3.6 for trivial pain. This cutoff represents pain of high frequency, high degree, or both. This cutoff was calculated as the sum of the choices made by the patients for questions 17, 18, and 19 as follows:

Answers for questions 17 and 18 include sometimes, most times, almost always, or always (3–1), and answer for question 19 include moderate, high, or very high (3–1). The sum of these three questions was then multiplied by the pain domain factor (0.4).

• 4. Psychiatric assessment

Structured Clinical Interview based on DSM-IV (SCID-I) [10] Arabic version [11]: It is used to diagnose an axis I diagnosis. It is applied to the case group for diagnosis of anxiety and depressive disorders. It is a semi-structured diagnostic interview based on DSM-IV that had been modified to DSM-5 clinical criteria. It is considered the standard interview to verify diagnosis in clinical trials and is extensively used in other forms of psychiatric research.

Beck Depression scale by Beck et al. [12] and Arabic version by Abdel-Khalek [13]: This is a self-report scale designed to assess DSM-IV-defined symptoms of depression such as sadness, guilt, loss of interest, social withdrawal, increase and decrease in appetite or sleep, suicidal ideation, and other behavioral manifestations of depression over time to monitor symptoms and to assess response to therapeutic interventions. It has an acceptable degree of validity, as it evaluates a wide variety of symptoms and attitudes associated with depression.

The inventory is composed of 21 statements on a four-point scale, with the patient selecting the one that best matches his or her current state. Each statement corresponds to a specific behavioral manifestation. Responses to each question are scored on a scale from 0–3, equivalent to no, mild, moderate, or severe disturbances. The score range of the inventory varies from 0 to 63, where a higher score indicates higher depressive symptom severity. According to Beck et al. [14], the scoring range is as follows: 0–13 indicate no or minimal depression, 14–19 indicate mild depression, 20–28 indicate moderate depression, and 29–63 indicate severe depression.

Beck Anxiety scale by Beck et al. [15] and Arabic version by Al-Issa et al. [16]: Beck Anxiety Inventory (BAI) is a 21-item multiple-choice self-report inventory that measures the severity of an anxiety. Each of the items on the Beck Anxiety Inventory is a simple description of a symptom of anxiety in one of its four expressed aspects: (A) subjective (e.g., “unable to relax”), (B) neurophysiologic (e.g., “numbness or tingling”), (C) autonomic (e.g., “feeling hot”), or (D panic-related (e.g., “fear of losing control”). It has acceptable reliability and validity.

Respondents are asked to report the extent to which they have been anxious by each of the 21 symptoms in the week preceding (including the day of) their completion of the BAI. Each symptom item has four possible answer choices: not at all, mildly (it did not bother me much), moderately (it was very unpleasant, but I could stand it), and severely (I could barely stand it). The clinician assigns the following values to each response: not at all = 0, mildly = 1, moderately = 2, and severely = 3. The values for each item are summed yielding an overall or total score for the 21 symptoms that can range between 0 and 63 points. Scores from 0 to 7 indicate a minimal level of anxiety. Scores from 8 to 15 indicate mild level of anxiety. Scores from 16 to 25 indicate moderate level of anxiety. Scores from 26 to 63 indicate severe level of anxiety.

Statistical methods of data analysis

Results were analyzed by the statistical package for social science (SPSS) version 23 [17]. Quantitative data were subjected to Shapiro-Wilk test to determine the distribution and method of analysis. Qualitative (categorical) data were presented by frequency and percentage. Quantitative data were presented by mean ± SD, median, and range. Mann-Whitney (Z test) and Kruskal-Wallis Test were used for non-parametric data. Spearman linear correlation coefficient (r) was estimated to show the relationship between quantitative parameters. Linear regression was used to ascertain the effect of possible risk factors on the pain score [18].

Results

The demographic data of the study population is summarized in (Table 1). This study included four hundred and fifty women living in Fayoum governorate. The age of the study group ranged between 18 and 66 years with a mean ± SD of 31.68 ± 9.26, and the age at marriage ranged between 12 and 40 years with a mean ± SD of 19.43 ± 3.69. The husband age ranged between 22 and 75 years old with mean ± SD of 38.33 ± 10.85. Sex acts/week were between 1 and 7 times with mean ± SD of 2.44 ± 0.85 (Table 1).

Table 1 Sociodemographic data of the studied group (n = 450)

As regard common causes of genital and gynecological pain over the past 4 weeks in the study participants, the most common cause was fungal infections, 95 (21.1%) females, then vaginal prolapse, genital wart, genital ulcer, and intrauterine adhesions (Table 1).

In the study group, 75 (16.7%) females had depressive symptoms as regards Beck Depression scale: one (0.2%) female had mild depression, 11 (2.4%) females had moderate depression, and 63 (14%) females had severe depression. As regards anxiety, 40 (8.9%) females had anxiety symptoms Beck Anxiety scale: 3 (0.7%) females had moderate degree of anxiety and 37 (8.2%) females had severe anxiety symptoms (Table 2).

Table 2 Psychiatric diagnosis among the studied females

The mean sexual pain among the included females was 4.75 ± 1.50 ranging from 0 to 6.0 (median 6). Marked pain (≤ 3.6) was reported by 142 females (31.6%, 95% CI 27.3–35.8), while trivial pain was reported by 308 females (68.4%, 95% CI 64.2–72.7) (Fig. 1).

Fig. 1

Prevalence of female sexual pain

Pain score had significant negative correlation with each of the depression score (r − 0.524, p < 0.001) and the anxiety score (r − 0.305, p < 0.001) (Fig. 2).

Fig. 2

Overlay scatter plot for pain score with depression score and anxiety score

There was no significant relation between the pain severity and different grades of the educational level, working status, comorbidities, menstrual cycle rhythm, contraception, or circumcision. Fungal infection, severe depression, and severe anxiety were significantly associated with marked severe pain. Patients with fungal infection had significantly marked severe pain than patients without any physical causes (< 0.001). Patients with severe depression had significantly marked severe pain than patients with minimal depression (p < 0.001 respectively). Patients with severe anxiety had significantly lower pain score than patients without (p < 0.001) (Tables 3 and 4).

Table 3 Association of the pain score with different risk factors

Table 4 Relation between pain severity and different risk factors

Univariate and multivariate linear regression revealed that depression, anxiety, and the presence of gynecological causes were significantly independent risk factors for more sexual pain (Table 5).

Table 5 Univariate linear regression of pain score with different risk factors

Discussion

Female sexual dysfunction is an irritating issue that is hard to be assessed in the Middle East countries due to its sensitive nature and the conservative traits of the population [19].

The prevalence of marked severe sexual pain in the study group was 31.6% of the studied group and the prevalence of trivial pain was 68.4% of the studied group. This was consistent with the global prevalence of the World Health Organization in 2006 that reported global prevalence of female sexual pain ranging between 8 and 21.1% [20] and also, consistent with systematic review in Brazil in 2016 that reported the prevalence of female sexual pain ranged from 1.2 to 56.1% [21].

In the present study, patients with gynecological causes especially fungal infection had significantly severe marked pain than patients without any other physical causes (< 0.001). This was consistent with Oshinowo et al. [22] whom showed that female sexual pain is believed to be a specific sexual pain disorder that can be accompanying vulvovaginitis.

In the present study, the most common cause of gynecological causes of female sexual pain was fungal infections 95 (21.1%) females. This was consistent with Nyirjesy [23] who stated that the most common etiology of chronic vaginal pain is recurrent vaginal fungal infection.

About 75% of women develop a fungal infection during their lifetime. Further studies indicate that five percent of women with vaginal fungal infections may develop recurrent vulvovaginal candidiasis [24].

The common symptoms of vulvovaginal fungal infection include pain during sexual intercourse [24, 25].

In the present study, there was no statistically significant relation between severity of pain and wives’ health problems, menstrual cycle, contraception and circumcision, education level of wives, and wives’ work. This was consistent with Selahittin et al. [26] who stated that there were no significant differences detected in marriage age, previous pelvic surgery, and contraception methods used between the women with and without sexual dysfunction including pain; however, they showed significantly higher prevalence of sexual dysfunction in the presence of older age, lower educational level, and unemployment, also, disagreed with Laumann et al. [27] who stated that low educated, unemployed, with chronic disease, multi-parried, and menopaused females had high risk of complaining of sexual problems.

In this study, patients with severe depression had significantly marked severe pain than patients with minimal depression (p < 0.001 respectively), which means that females suffered higher levels of depression and had higher marked pain and higher feeling of sexual pain more than others.

This was consistent with Atlantis and Sullivan [28] and Evan and Thomas [29] who stated that the chance of having sexual dysfunction including pain (which is the aim of this study) as well as desire, arousal, satisfaction, and orgasm is increased by depression. Also, it was consistent with Frohlich and Meston [30] who reported that depressive women felt higher sexual pain, along with low sexual arousal than controls without depression.

In this study, patients with severe anxiety had significantly lower pain score than patients without (p < 0.001), which means that females who suffered from higher levels of anxiety had higher marked pain and a higher feeling of sexual pain more than others. That confirms the positive correlation between sexual pain and anxiety. And this was consistent with Kimberley et al. [31] who stated that hyper vigilance to pain stimuli in women suffering anxiety may result in both a heightened awareness of pain and a distraction away from sexual stimuli resulting in impaired sexual arousal, which itself may potentially exacerbate the pain experience. Also, this agreed with Payne et al. [31] who stated that women with anxiety who usually have high threshold to pain stimuli would over expect the feeling of pain and subsequently would distract away from sexual stimuli that eventually would lead to impaired sexual function. That itself may potentially augment the pain experience.

In the present study, pain score (low pain scores means high degree and high frequency of pain) had significant negative correlation with each of the depression score (r − 0.524, p < 0.001) and the anxiety score (r − 0.305, p < 0.001). This agreed with Rossi et al. [5] and Burri et al. [32] who found that female sexual pain had significant anxiety (p value < 0.01) and depression (p value < 0.01).

In the present study, univariate and multivariate linear regression revealed that depression anxiety and the presence of gynecological causes especially fungal infections were significantly independent risk factors for more sexual pain. Similarly, Khandker et al. [33] found that anxiety and depression were an independent risk factor for female sexual pain that increases the risk of such disorders, highlighting the bidirectional temporal relationship between sexual pain and such psychiatric symptoms. Although the relationship between painful sexual intercourse and depressive and anxiety symptoms is well-documented, the factors that are driving this relationship and the temporal associations among these factors have yet to be elucidated.

Also, females who feel sexual pain are likely to complain from psychiatric symptoms, in particular increased depressive symptoms [33,34,35,36].

Several study limitations should be taken in consideration. First, the cross-sectional nature of this study could not confirm the temporal relationships between sexual pain and psychiatric symptoms. Further longitudinal or experimental designs would further elucidate the directionality of these relationships. Second, other studies are needed to know how other comorbid pain factors are correlated with sexual functioning and psychiatric symptoms. Third, future studies should examine these relationships in women who are not currently sexually active, as pain during intercourse might prevent women from engaging in sexual intercourse.

Conclusion

Depression anxiety and gynecological causes especially fungal infections were independent risk factors for female sexual pain. We strongly recommended putting into consideration the importance of searching for psychiatric disorders during assessment and treatment of females suffering from sexual pain. And the urgent need for an integrated approach with co-operation between sexologists and psychiatrists in this conflict.